Marshall Wace’s Akebia Therapeutics AKBA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-247,069
Closed -$252K 2254
2024
Q2
$252K Sell
247,069
-776,206
-76% -$792K ﹤0.01% 2024
2024
Q1
$1.87M Buy
+1,023,275
New +$1.87M ﹤0.01% 1218
2022
Q4
Sell
-314,316
Closed -$101K 2289
2022
Q3
$101K Buy
+314,316
New +$101K ﹤0.01% 2412
2022
Q1
Sell
-4,475,138
Closed -$10.1M 2564
2021
Q4
$10.1M Sell
4,475,138
-2,493,673
-36% -$5.64M 0.02% 789
2021
Q3
$20.1M Buy
6,968,811
+2,859,222
+70% +$8.23M 0.08% 229
2021
Q2
$15.6M Buy
+4,109,589
New +$15.6M 0.07% 265
2020
Q4
Sell
-38,578
Closed -$97K 1706
2020
Q3
$97K Sell
38,578
-322,389
-89% -$811K ﹤0.01% 1480
2020
Q2
$4.9M Buy
+360,967
New +$4.9M 0.03% 460
2019
Q2
Sell
-37,263
Closed -$305K 1273
2019
Q1
$305K Sell
37,263
-496,678
-93% -$4.07M ﹤0.01% 1252
2018
Q4
$2.95M Sell
533,941
-5,123
-1% -$28.3K 0.03% 623
2018
Q3
$4.76M Sell
539,064
-195
-0% -$1.72K 0.04% 462
2018
Q2
$5.38M Buy
539,259
+304,490
+130% +$3.04M 0.08% 280
2018
Q1
$2.24M Buy
234,769
+30,573
+15% +$291K 0.09% 180
2017
Q4
$3.04M Buy
204,196
+114,349
+127% +$1.7M 0.13% 147
2017
Q3
$1.8M Sell
89,847
-7,447
-8% -$149K 0.08% 171
2017
Q2
$1.36M Buy
97,294
+44,577
+85% +$624K 0.06% 156
2017
Q1
$474K Sell
52,717
-635,753
-92% -$5.72M 0.02% 248
2016
Q4
$7.17M Buy
688,470
+66,620
+11% +$694K 0.05% 397
2016
Q3
$5.63M Buy
621,850
+160,333
+35% +$1.45M 0.04% 384
2016
Q2
$3.45M Buy
461,517
+6,911
+2% +$51.7K 0.03% 461
2016
Q1
$4.1M Buy
454,606
+82,931
+22% +$747K 0.04% 391
2015
Q4
$4.8M Sell
371,675
-56,357
-13% -$728K 0.05% 390
2015
Q3
$4.14M Buy
428,032
+28,032
+7% +$271K 0.05% 325
2015
Q2
$4.12M Buy
+400,000
New +$4.12M 0.05% 329